One year of liraglutide treatment offers sustained and more effective glycaemic control and weight reduction compared with sitagliptin, both in combination with metformin, in patients with type 2 diabetes: a randomised, parallel-group, open-label trial
A compounding pharmacist reformulates it into a grape-flavored suspension, making adherence much easier
"GLP-1s can be life-changing for patients managing obesity and related conditions," Chris Klomp, director of Medicare and chief counselor at the U.S
Together, they provide comprehensive support for your immune system, ensuring that your body is prepared to fight off infections
The Short Answer: The best available human evidence does not show that GLP-1 receptor agonists cause common thyroid cancers or even has an effect if you have developed a thyroid cancer